August 2026– date –
-
Upstate Cancer Center Engineers Magnetically-Guided Nanoparticles for Targeted Chemotherapy, Achieving Tumor Shrinkage with Minimal Side Effects
Upstate Cancer Center (Facebook) USA Overview Researchers at Upstate Cancer Center have developed magnetically-guided nanoparticles (10-100 nm) for targeted chemotherapy, demonstrating tumor shrinkage while significantly reducing systemi... -
Protein Interactions Shed New Light on Autism Causes: Advancing Neurological Disease Understanding
Fierce Biotech USA Overview Research reports that complex protein-protein interactions offer new insights into the fundamental causes of autism spectrum disorder (ASD). This discovery is a critical step towards understanding the intricat... -
Bridging the Data Integrity Gap in Pharmaceutical Quality Control: Ensuring Reliability for Advanced Medicinal Products
European Pharmaceutical Review EU Overview The critical importance of closing the data integrity gap in pharmaceutical quality control has been re-emphasized. For advanced medicinal products like cell and gene therapies, stringent reliab... -
MSD-Moderna Personalized mRNA Neoantigen Combination Adjuvant Therapy Reports Positive Phase III Results in Melanoma
European Pharmaceutical Review USA Overview MSD (Merck) and Moderna's personalized mRNA neoantigen combination adjuvant therapy has announced positive results from its Phase III clinical trial in high-risk melanoma patients. The data sug... -
European Commission Approves Acadia’s Trofinetide as First EU Rett Syndrome Treatment
European Pharmaceutical Review EU Overview The European Commission (EC) has approved Acadia Pharmaceuticals' trofinetide as the first treatment for Rett syndrome in the European Union. This approval represents a landmark advancement, off... -
FDA Approves First Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa), Offering New Option for Patients Aged 8+
Pharmacy Times USA Overview The U.S. FDA has approved the first gene therapy for Glycogen Storage Disease Type Ia (GSDIa), targeting the underlying cause of this rare metabolic disorder in patients aged 8 and older. GSDIa results from a ... -
Decoding Hashimoto’s: Exosomes Emerge as Pivotal for Diagnosis and Therapy
PubMed International Overview A groundbreaking study reveals the critical role of exosomes in the pathogenesis of Hashimoto's thyroiditis, positioning them as promising new diagnostic biomarkers and therapeutic targets. The research deta... -
Regenxbio’s Hunter Syndrome Gene Therapy Refiling Halted by Second FDA Clinical Hold
Fierce Biotech USA Overview Regenxbio's plan to refile its gene therapy for Hunter syndrome (MPS II) has been derailed by a clinical hold imposed by the FDA, leading the company to postpone its regulatory submission indefinitely. This ma... -
Broad Institute Achieves Long-Term Brain Organoid Longevity and Streamlines Prime Editing with AI
Broad Institute USA Overview The Broad Institute announced a significant milestone on August 20, 2026, where an AI model streamlined the prime editing process and enabled the long-term longevity of brain organoids. The institute actively... -
Cellistic Expands iPSC Therapy Manufacturing with New GMP Platforms for Immuno-Oncology and Regenerative Medicine
Cellistic Press Release (via PharmaTimes) Belgium Overview Cellistic has introduced three new GMP manufacturing platforms—Echo-T, Echo-Cardio, and Echo-Endothelial—significantly expanding its capabilities for iPSC-derived cell therapies....
